Search results for "From ACP Internist Weekly"
Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD
pathway from the American College of Cardiology. ... All articles from the December 14, 2018, ACP Diabetes Monthly Newsletter.
December 2018
New guideline offers recommendations for older patients with diabetes or prediabetes
a reduction in the minimum estimated glomerular filtration rate at which dapagliflozin may be prescribed from 60 mL/min/1.73 m. ... All articles from the April 5, 2019, ACP Diabetes Monthly Newsletter.
April 2019
Diabetes Collaborative Registry seeks primary care participants
ACP has partnered with the American College of Cardiology to participate in the Diabetes Collaborative Registry, a national clinical diabetes registry and interdisciplinary collaboration designed to assess and improve the quality ... ACP has partnered
August 2015
Preoperative factors may help predict long-term weight outcomes after gastric bypass, study finds
Using electronic health records from 1 health system, researchers followed 726 patients (mean age, 45.2 years; 83.1% women) for 7 to 12 years after Roux-en-Y gastric bypass ... All articles from the September 16, 2016, ACP Diabetes Monthly Newsletter.
September 2016
Kidney failure, CV events lower with canagliflozin than placebo, industry study finds
stage kidney disease, doubling of creatinine, or death from renal causes) (HR, 0.66; 95% CI, 0.53 to 0.81; P < 0.001) with the drug. ... All articles from the May 10, 2019, ACP Diabetes Monthly Newsletter.
May 2019
SGLT2 inhibitors associated with rare, life-threatening necrotizing genital infections
Twelve patients were men and seven were women, with an age range from 42 to 79 years. ... All articles from the May 10, 2019, ACP Diabetes Monthly Newsletter.
May 2019
Newer, older insulin formulations may offer similar glucose-lowering effects
Glargine, 300 U/mL (Glar-300), had a favorable weight profile compared with degludec, 100 U/mL (Deg-100); degludec, 200 u/mL (Deg-200); thrice-weekly degludec (Deg-3TW); glargine, ... wrote. All articles from the July 13, 2018, ACP Diabetes Monthly
July 2018
Task Force recommends screening for type 2 diabetes in overweight, obese adults
To update this recommendation, the USPSTF commissioned an evidence review that was published online April 14 by Annals of Internal Medicine and covered in the April 14 ACP Internist Weekly. ... All articles from the November 13, 2015, ACP Diabetes
November 2015
Analysis finds several treatments for painful diabetic neuropathy more effective than placebo
All articles from the November 14, 2014, ACP Diabetes Monthly Newsletter.
November 2014
Patients on tramadol more likely to be hospitalized for hypoglycemia
The observational case-control analysis used data from the United Kingdom Clinical Practice Research Datalink to find patients newly treated with tramadol or codeine for noncancer pain between 1998 and 2012. ... All articles from the January 9, 2015, ACP
January 2015